Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

The coronavirus disease 2019 (COVID-19) pandemic has become a severe healthcare problem worldwide since the first outbreak in late December 2019. Currently, the COVID-19 vaccine has been used in many countries, but it is still unable to control the spread of severe acute respiratory syndrome coronav...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanokudom, Sitthichai, Assawakosri, Suvichada, Suntronwong, Nungruthai, Auphimai, Chompoonut, Nilyanimit, Pornjarim, Vichaiwattana, Preeyaporn, Thongmee, Thanunrat, Yorsaeng, Ritthideach, Srimuan, Donchida, Thatsanatorn, Thaksaporn, Klinfueng, Sirapa, Sudhinaraset, Natthinee, Wanlapakorn, Nasamon, Honsawek, Sittisak, Poovorawan, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779615/
https://www.ncbi.nlm.nih.gov/pubmed/35062747
http://dx.doi.org/10.3390/vaccines10010086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779615/
https://www.ncbi.nlm.nih.gov/pubmed/35062747
http://dx.doi.org/10.3390/vaccines10010086

Ejemplares similares